Good evening :)
Place Order
Add to Watchlist

Ajanta Pharma Ltd

AJANTPHARM Share Price

2,790.403.77% (+101.50)

AJANTPHARM Share Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
MidcapWith a market cap of ₹33,587 cr, stock is ranked 234
Moderate RiskStock is 2.48x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
MidcapWith a market cap of ₹33,587 cr, stock is ranked 234
Moderate RiskStock is 2.48x as volatile as Nifty

AJANTPHARM Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
37.419.421.92%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.616.440.53%

AJANTPHARM Analyst Ratings & Forecast

Detailed Forecast 
80%
Analysts have suggested that investors can buy this stock

from 10 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

AJANTPHARM Company Profile

Ajanta Pharma Limited is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations.

AJANTPHARM Similar Stocks (Peers)

Compare with peers 
PE Ratio
44.82
1Y Return
21.41%
Buy Reco %
88.24
PE Ratio
30.05
1Y Return
10.98%
Buy Reco %
72.73
PE Ratio
68.09
1Y Return
23.77%
Buy Reco %
68.00
PE Ratio
54.90
1Y Return
8.38%
Buy Reco %
81.25
PE Ratio
17.69
1Y Return
0.87%
Buy Reco %
46.67
Compare with Peers

AJANTPHARM Forecasts

Price

Revenue

Earnings

AJANTPHARM

Income

Balance Sheet

Cash Flow

AJANTPHARM Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 15.64%, vs industry avg of 9.04%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.95% to 1.13%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 16.1%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue1,770.522,007.122,149.922,076.452,680.062,915.673,456.673,841.284,293.314,643.66
Raw Materialssubtract463.10425.21455.63440.09672.46795.95915.441,024.641,105.783,291.10
Power & Fuel Costsubtract15.4918.7027.4232.6538.8843.7054.3865.7166.57
Employee Costsubtract256.64295.42376.47430.71485.59548.25645.78785.14900.34
Selling & Administrative Expensessubtract327.55362.94424.71445.52534.89484.01652.72784.97749.71
Operating & Other expensessubtract99.53194.11183.14139.97176.6419.22143.37298.93214.37
Depreciation/Amortizationsubtract44.4361.2159.5972.0895.72116.09125.30130.80135.40138.58
Interest & Other Itemssubtract4.891.360.411.1611.918.2710.205.847.2116.19
Taxes & Other Itemssubtract143.28141.34153.91127.30196.27246.31196.80157.27297.76299.94
EPS31.3638.2335.1929.1835.4249.7354.7845.9464.4370.87
DPS5.338.670.006.008.676.336.337.0051.0054.00
Payout ratio0.170.230.000.210.240.130.120.150.790.76

AJANTPHARM Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2018

Annual report

PDF

Investor Presentation

May 2PDF
Jan 25PDF
Oct 31PDF
FY 2019

Annual report

PDF

Investor Presentation

Apr 30PDF
Jan 30PDF
Oct 31PDF
Jul 31PDF
FY 2020

Annual report

PDF

Investor Presentation

Feb 5PDF
Nov 5PDF
Jul 31PDF
 

AJANTPHARM Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Ajanta Pharma Ltd41.159.421.92%
Sun Pharmaceutical Industries Ltd44.826.400.75%
Cipla Ltd30.054.620.85%
Torrent Pharmaceuticals Ltd68.0916.450.84%

AJANTPHARM Stock Price Comparison

Compare AJANTPHARM with any stock or ETF
Compare AJANTPHARM with any stock or ETF
AJANTPHARM
Loading...

AJANTPHARM Shareholdings

AJANTPHARM Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

AJANTPHARM Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

AJANTPHARM Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding66.26%15.13%2.35%8.86%7.40%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

AJANTPHARM Shareholding History

Dec '23MarJunSepDec '24Mar9.11%8.54%8.36%9.11%9.26%8.86%

Mutual Funds Invested in AJANTPHARM

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Ajanta Pharma Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
1.3077%0.79%-0.05%23/244 (0)
1.0277%1.41%-0.06%28/68 (-22)
0.9522%2.04%0.41%49/81 (+2)

Compare 3-month MF holding change on Screener

AJANTPHARM Insider Trades & Bulk Stock Deals

Loading...

smallcases containing AJANTPHARM stock

A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Ajanta Pharma Ltd

Loading...
Pharma Tracker

Pharma Tracker

Created by Windmill Capital

AJANTPHARM's Wtg.
9.25%
CAGR
15.32%

AJANTPHARM Events

AJANTPHARM Dividend Trend

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.92%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹19.24 every year

Dividends

Corp. Actions

Announcements

Legal Orders

AJANTPHARM Upcoming Dividends

No upcoming dividends are available

AJANTPHARM Past Dividends

Cash Dividend

Ex DateEx DateNov 6, 2024

Interim 1
Interim 1 | Div/Share: ₹28.00

Dividend/Share

28.00

Ex DateEx Date

Nov 6, 2024

Cash Dividend

Ex DateEx DateFeb 8, 2024

Interim 2
Interim 2 | Div/Share: ₹26.00

Dividend/Share

26.00

Ex DateEx Date

Feb 8, 2024

Cash Dividend

Ex DateEx DateAug 4, 2023

Interim 1
Interim 1 | Div/Share: ₹10.00

Dividend/Share

10.00

Ex DateEx Date

Aug 4, 2023

Cash Dividend

Ex DateEx DateAug 4, 2023

Special
Special | Div/Share: ₹15.00

Dividend/Share

15.00

Ex DateEx Date

Aug 4, 2023

Cash Dividend

Ex DateEx DateNov 11, 2022

Interim
Interim | Div/Share: ₹7.00

Dividend/Share

7.00

Ex DateEx Date

Nov 11, 2022

AJANTPHARM Stock News & Opinions

Corporate
Ajanta Pharma to discuss results

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 April 2025.Powered by Capital Market - Live

2 days agoCapital Market - Live
Spotlight
Ajanta Pharma Ltd spurts 2.5%, up for five straight sessions

Ajanta Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2786.7, up 2.5% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.89% on the day, quoting at 23273.05. The Sensex is at 76963.3, down 0.7%. Ajanta Pharma Ltd has dropped around 5.45% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has dropped around 8.32% in last one month and is currently quoting at 21334.8, down 0.85% on the day. The volume in the stock stood at 62022 shares today, compared to the daily average of 1.26 lakh shares in last one month.The PE of the stock is 38.32 based on TTM earnings ending December 24.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Ajanta Pharma consolidated net profit rises 10.88% in the December 2024 quarter

Net profit of Ajanta Pharma rose 10.88% to Rs 232.88 crore in the quarter ended December 2024 as against Rs 210.03 crore during the previous quarter ended December 2023. Sales rose 3.71% to Rs 1146.13 crore in the quarter ended December 2024 as against Rs 1105.15 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1146.131105.15 4 OPM %27.9928.42 - PBDT343.36325.17 6 PBT307.39290.91 6 NP232.88210.03 11 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Ajanta Pharma to conduct board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 January 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
FMCG shares fall

Among the components of the BSE Fast Moving Consumer Goods index, ADF Foods Ltd (down 3.98%), Gokul Agro Resources Ltd (down 3.81%),Dalmia Bharat Sugar & Industries Ltd (down 3.55%),Hindustan Foods Ltd (down 3.05%),Gillette India Ltd (down 2.7%), were the top losers. Among the other losers were Cupid Ltd (down 2.59%), KRBL Ltd (down 2.36%), CCL Products (India) Ltd (down 2.25%), Dodla Dairy Ltd (down 2.17%), and Bikaji Foods International Ltd (down 2%). On the other hand, Godfrey Phillips India Ltd (up 7.81%), Prataap Snacks Ltd (up 3.87%), and Gulshan Polyols Ltd (up 2.9%) moved up.At 13:46 IST, the BSE SmallCap was down 219.24 or 0.4% at 54803.93.The BSE 150 MidCap Index index was down 47.43 points or 0.3% at 15843.73.The Nifty 50 index was up 27.45 points or 0.12% at 23755.099609375.The BSE Sensex index was up 33.38 points or 0.04% at 78506.25.On BSE,1555 shares were trading in green, 2353 were trading in red and 127 were unchanged.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Real Estate shares fall

Among the components of the BSE Realty index, Brigade Enterprises Ltd (down 1.82%), Anant Raj Ltd (down 1.57%),Prestige Estates Projects Ltd (down 1.36%),Phoenix Mills Ltd (down 0.9%),Sobha Ltd (down 0.69%), were the top losers. Among the other losers were Godrej Properties Ltd (down 0.6%), and DLF Ltd (down 0.43%). On the other hand, SignatureGlobal India Ltd (up 3.41%), Oberoi Realty Ltd (up 0.37%), and Macrotech Developers Ltd (up 0.26%) moved up.At 13:46 IST, the BSE SmallCap was down 219.24 or 0.4% at 54803.93.The BSE 150 MidCap Index index was down 47.43 points or 0.3% at 15843.73.The Nifty 50 index was up 27.45 points or 0.12% at 23755.099609375.The BSE Sensex index was up 33.38 points or 0.04% at 78506.25.On BSE,1555 shares were trading in green, 2353 were trading in red and 127 were unchanged.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Basic materials shares fall

Among the components of the BSE Commodities index, Sadhana Nitro Chem Ltd (down 8.63%), Hindustan Copper Ltd (down 6.04%),Sunflag Iron & Steel Company Ltd (down 5.04%),Platinum Industries Ltd (down 3.87%),I G Petrochemicals Ltd (down 3.58%), were the top losers. Among the other losers were Fairchem Organics Ltd (down 3.28%), Chemplast Sanmar Ltd (down 3.04%), Indian Metals & Ferro Alloys Ltd (down 3.01%), Ashapura Minechem Ltd (down 2.98%), and Best Agrolife Ltd (down 2.96%). On the other hand, Saurashtra Cement Ltd (up 12.81%), Himadri Speciality Chemical Ltd (up 3.47%), and Sarda Energy & Minerals Ltd (up 2.92%) moved up.At 13:46 IST, the BSE SmallCap was down 219.24 or 0.4% at 54803.93.The BSE 150 MidCap Index index was down 47.43 points or 0.3% at 15843.73.The Nifty 50 index was up 27.45 points or 0.12% at 23755.099609375.The BSE Sensex index was up 33.38 points or 0.04% at 78506.25.On BSE,1555 shares were trading in green, 2353 were trading in red and 127 were unchanged.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Ajanta Pharma Ltd slips for fifth straight session

Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2759.3, down 1.59% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.09% on the day, quoting at 23749.599609375. The Sensex is at 78483.64, up 0.01%.Ajanta Pharma Ltd has lost around 8.84% in last one month.Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has increased around 3.32% in last one month and is currently quoting at 22558.9, down 0.03% on the day. The volume in the stock stood at 48570 shares today, compared to the daily average of 1.15 lakh shares in last one month.The PE of the stock is 40.98 based on TTM earnings ending September 24.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Ajanta Pharma Ltd soars 1.25%, up for fifth straight session

Ajanta Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs 2982.3, up 1.25% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 1.39% on the day, quoting at 23674.85. The Sensex is at 78171.81, up 1.32%. Ajanta Pharma Ltd has risen around 1.22% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has risen around 2.56% in last one month and is currently quoting at 21740.1, up 0.71% on the day. The volume in the stock stood at 25123 shares today, compared to the daily average of 1.02 lakh shares in last one month.The PE of the stock is 43.16 based on TTM earnings ending September 24.Powered by Capital Market - Live

5 months agoCapital Market - Live
Spotlight
Ajanta Pharma Ltd gains for third straight session

Ajanta Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 2929.25, up 1.39% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.25% on the day, quoting at 23745.85. The Sensex is at 78340.19, up 1.29%. Ajanta Pharma Ltd has slipped around 6.72% in last one month. Meanwhile, Nifty Pharma index of which Ajanta Pharma Ltd is a constituent, has slipped around 5.27% in last one month and is currently quoting at 21544.15, up 1.67% on the day. The volume in the stock stood at 16566 shares today, compared to the daily average of 1.04 lakh shares in last one month.The PE of the stock is 42.23 based on TTM earnings ending September 24.Powered by Capital Market - Live

5 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of Ajanta Pharma Ltd (AJANTPHARM) today?

    The share price of AJANTPHARM as on 24th April 2025 is ₹2790.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Ajanta Pharma Ltd (AJANTPHARM) share?

    The past returns of Ajanta Pharma Ltd (AJANTPHARM) share are
    • Past 1 week: 1.48%
    • Past 1 month: -2.22%
    • Past 3 months: -0.22%
    • Past 6 months: -6.08%
    • Past 1 year: 30.78%
    • Past 3 years: 136.48%
    • Past 5 years: 189.87%

  3. What are the peers or stocks similar to Ajanta Pharma Ltd (AJANTPHARM)?
  4. What is the dividend yield % of Ajanta Pharma Ltd (AJANTPHARM) share?

    The current dividend yield of Ajanta Pharma Ltd (AJANTPHARM) is 1.92.

  5. What is the market cap of Ajanta Pharma Ltd (AJANTPHARM) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ajanta Pharma Ltd (AJANTPHARM) is ₹33587.61 Cr as of 24th April 2025.

  6. What is the 52 week high and low of Ajanta Pharma Ltd (AJANTPHARM) share?

    The 52-week high of Ajanta Pharma Ltd (AJANTPHARM) is ₹3485 and the 52-week low is ₹2111.05.

  7. What is the PE and PB ratio of Ajanta Pharma Ltd (AJANTPHARM) stock?

    The P/E (price-to-earnings) ratio of Ajanta Pharma Ltd (AJANTPHARM) is 41.15. The P/B (price-to-book) ratio is 9.42.

  8. Which sector does Ajanta Pharma Ltd (AJANTPHARM) belong to?

    Ajanta Pharma Ltd (AJANTPHARM) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Ajanta Pharma Ltd (AJANTPHARM) shares?

    You can directly buy Ajanta Pharma Ltd (AJANTPHARM) shares on Tickertape. Simply sign up, connect your demat account and place your order.